4.1 Review

Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals

Related references

Note: Only part of the references are listed.
Article Neurosciences

Efficacy of Aripiprazole in Comorbid Addiction in Bipolar Disorder

Pierre Alexis Geoffroy et al.

CNS NEUROSCIENCE & THERAPEUTICS (2012)

Review Endocrinology & Metabolism

The multiple functions of the endocannabinoid system: a focus on the regulation of food intake

Eduardo Tibirica

DIABETOLOGY & METABOLIC SYNDROME (2010)

Review Psychiatry

The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway

Oliver D. Howes et al.

SCHIZOPHRENIA BULLETIN (2009)

Letter Clinical Neurology

Aripiprazole diminishes cannabis use in schizophrenia

Martin Desseilles et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2008)

Article Psychiatry

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia

LA Nunez et al.

ACTA PSYCHIATRICA SCANDINAVICA (2002)